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Abstract
Fasciola hepatica is a worldwide distributed helminth pathogen that causes great economic losses in sheep and
cattle. This parasite is able to regulate the host immune response, producing high levels of IL-5 and low levels of
IFNγ, as well as modulating the function of dendritic cells (DCs), mast cells or macrophages, among others.
Moreover, TLR-mediated maturation of DCs can be suppressed by F. hepatica derived components. Here, we
investigated the role of glycans in the modulation of LPS-induced maturation of DCs, as well as in the production of
IL-5 and IFNγ by splenocytes from infected mice. We show that F. hepatica induces the recruitment to the
peritoneum of semi-matured DCs, as judged by a down-regulation of MHC class II molecule expression and an
increase of CD80 and CD86 expression of DCs in the peritoneum of infected animals. Furthermore, we provide
evidence indicating that glycan structures from F. hepatica are responsible, at least in part, for inhibiting LPS-
induced DC maturation and production of IFNγ by splenocytes from infected animals. On the other hand, we show
that a mucin-like non-glycosylated peptide highly expressed in NEJ (Fhmuc) is able to synergize with LPS in
inducing DC-maturation, and that it induces a T cell response specific for F. hepatica, both alone or in combination
with DCs. Our data highlight the role of F. hepatica glycans in modulating the host immune response and might
contribute to the design of vaccines against fasciolosis.
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Abbreviations:
BMDCs: Bone Marrow Derived Dendritic Cells; DCs: Dendritic
Cells; FhTE: F. hepatica Total Extract; FhPox: F. hepatica Oxidized
Total Extract; FhB: F. hepatica Borohydride-Treated Total Extract;
ND: Not Done; MHC: Major Histocompatibility Complex; SD:
Standard Deviation; TLR: Toll-Like Receptor.
Introduction
Fasciolosis is a major parasitic disease of livestock causing
significant economic losses worldwide [1]. Currently, fasciolosis is also
considered an emerging zoonoses with increasing number of people
infected around the world [1]. In temperate regions this disease is
caused by the liver fluke Fasciola hepatica. During infection, this
pathogen induces potent polarized Th2/Treg immune responses,
suppressing the production of Th1 cytokines [2-5]. Thus, the parasite
is able to modulate the host immune response by increasing the
production of IL-4, IL-5, IL-10 or TGFβ[2,6], and inhibiting the levels
of IFNγ or IL-17 [2,5].
This strategy allows the parasite establish chronic infections and
prolongs its survival in the host. In this context, liver fluke infection
has shown to increase susceptibility to other infectious diseases, such
as bovine tuberculosis thus affecting the efficacy of control programs
[7].
Many lines of evidence indicate that the evasion immune
mechanisms that are utilized by helminths, including Fasciola,
comprise, for instance, the modulation of maturation and function of
dendritic cells (DCs) [8-10], the impairment of mast cell activation
[11-12], an increase of regulatory T cells (Tregs) [2], the alternative
activation of macrophages [13], the production of immune-
suppressive cytokines by the host [6], the proteolytic cleavage of
antibodies by parasite proteases [14], or the apoptosis of eosinophils
[15] or macrophages [16], and are subject of ongoing investigation
nowadays.
DCs are potent antigen presenting cells that possess the ability to
stimulate naive T cells. In response to infectious agents DCs undergo a
maturation process during which they migrate to secondary lymphoid
organs where they present captured antigens to naive T cells, for the
triggering of specific immunity. This process is associated to an up-
regulation of the expression of MHC molecules, adhesion molecules
and co-stimulatory molecules as well as a down-regulation of their
endocytotic capacity [17].
DCs matured in the presence of helminth antigens express reduced
levels of co-stimulatory markers (CD40, CD80 or CD86) and MHC
class II molecules, as compared to DCs matured with Toll-like
receptor (TLR) ligands such as lipopolysaccharide (LPS) [18]. Also,
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these DCs are not capable of producing high levels of pro-
inflammatory cytokines (IL-12, IL-6 or TNFα) [18]. In this sense,
independent in vitro studies have reported that different Fasciola
hepatica components suppress TLR-initiated DC maturation and their
stimulatory function [8-10].
Helminths express various carbohydrates-containing
glycoconjugates on their surface and they release glycan-rich
excretion/secretion products that can be very important in their life
cycles and pathology [19]. Carbohydrate-signatures from parasites are
decoded by the immune system through the interaction of several
immune receptors. In particular, receptors of the innate branch that
recognize glycan motifs consist of soluble or membrane-associated
lectins, siglecs and scavenger receptors, among others. Notably, C-type
lectin receptors (CLRs) have been described to mediate internalization
of parasite glycosylated molecules as well as cell-surface signaling [20].
Certain helminth parasites also express mucin-like molecules, the
major carriers of O-glycans [21]. They can participate in attachment
and invasion of host cells among other processes, by providing
resistance to proteolytic attack or avoiding immune recognition [21].
Interestingly, the CLR Dectin-1 seems to mediate the recognition of F.
hepatica glycans and may be involved in the alternative activation of
macrophages [22].
Little is known about the glycans produced by F. hepatica, with only
two reports describing lectin reactivity in the miracidial surface [23] or
in the gut of adult flukes [24], suggesting the presence of mannose and
glucose residues, and other describing Galβ1-6Gal-terminating
glycolipids by mass spectrometry [25]. Also, our group has previously
described, the expression of the GalNAc-O-Ser/Thr structure (known
as Tn antigen) [26]. Recently, during a characterization of the
transcriptome of F. hepatica newly excysted juveniles (NEJ) a cDNA
clone coding for a mucin-like protein highly expressed in the infected
stage, has been identified [27].
In this paper we evaluate the role of F. hepatica glycans at a systemic
level and show that glycans inhibit IFNγ production of specific
splenocytes from infected animals. Furthermore, we show that F.
hepatica induces a recruitment of DCs to the peritoneum during
infection and modulates DC activation judged by a down-regulation of
MHC class II molecule expression in infected animals. In vitro, we
demonstrate that this DC-immunomodulation can be mediated by
glycans. Finally, we evaluate the immunological properties of a mucin-
like peptide (Fhmuc) highly expressed in juveniles, and present
preliminary data indicating that this mucin-like peptide is able to
induce parasite-specific Th1-polarized cell response. Moreover, when
administered in combination with DCs, the IFNγ producing T cells
immune response is stronger, since it synergizes with LPS in inducing




Six- to 8-week-old female C57BL/6 or BALB/c mice were obtained
from DILAVE Laboratories (Uruguay). Animals were kept in the
animal house (URBE, Facultad de Medicina, UdelaR, Uruguay) with
water and food supplied ad libitum, and handled in accordance with
institutional guidelines for animal welfare by the Committee on
Animal Research (Comisión Honoraria de Experimentación Animal,
CHEA, Uruguay).
Preparation of protein lysates from F. hepatica
Live adult worms of F. hepatica were obtained from the bile ducts of
bovine livers and then washed for 1 h at 37°C with phosphate buffered
saline (PBS) pH 7.4. Total parasite lysates (FhTE) were prepared by
incubation of washed adults flukes in PBS, sonicated and centrifuged
at 40,000 × g for 60 min. Carbohydrate glycol groups present in FhTE
were oxidized with sodium periodate (10 mM). The oxidation was
performed at room temperature for 45 minutes, followed by the
reduction with sodium borohydride (100 mM) of the reactive aldehyde
groups. The resulting oxidized lysate is referred as FhPox. In order to
perform control experiments, the following control extracts were
prepared: FhB, consisted of FhTE subjected to the whole treatment
excepting for the incubation with sodium periodate; and CPox,
consisting in PBS subjected to the entire treatment. Lysates were
dialyzed against PBS and their protein concentration was measured
using the bicinchoninic acid assay (Sigma, St. Louis, MO, USA). To
remove endotoxin contamination, FhTE was applied to a column
containing endotoxin removing gel (detoxi-gel, Pierce Biotechnology).
The endotoxin levels were determined by using the Limulus
Amebocyte Lysate kit Pyrochrome (Associates of Cape Cod). Protein
preparations showed very low levels of endotoxins and were not able
to induce DC maturation (as IL-12 read out) on their own. The
concentration of F. hepatica extracts used in culture experiments did
not modify cell viability.
Infections and cell culture
Animals (5 per group) were orally infected with 5 (for BALB/c) or
10 (for C57BL/6) F. hepatica metacercariae (Baldwin Aquatics, USA)
per animal. After 3 weeks of infection spleens and peritoneal exudates
cells (PECs) were removed. PECs were harvested by washing the
peritoneal cavity with 10 mL of PBS. Splenocytes or PECs (0.5-1×106
cells/mL) were cultured in complete medium consisting of RPMI-1640
with glutamine (PAA Laboratories, Austria) supplemented with 10%
heat-inactivated fetal bovine serum (FBS), 50 µM 2-mercaptoethanol,
100 U/ml penicillin and 100 mg/ml streptomycin (Sigma, St. Louis,
MO, USA), in the presence or absence of FhTE (75 µg/ml), FhPox (75
µg/ml), Fhmuc (10 µg/ml) and the controls FhB or CPox, for 72 h at
37˚C and 5% CO2. IFNγ and IL-5 levels were tested on culture
supernatants by interleukin- specific sandwich ELISA assays (BD
Bioscience, NJ, USA). Uninfected naive animals were used as a control
group.
T cell response
A 66 amino acid sequence of a F. hepatica mucin like-protein,
named Fhmuc, was synthesized by Peptide 2.0 Inc (Virginia, USA).
The amino acid sequence of the peptide
isVSSDASTTSTTMTARSSSASATASSETRAPSSTMTTQNASTTSGS
VRLPIQTTRCILLFIFG VAFF.
Mice were immunized intraperitoneally (i.p.) with Fhmuc (10 µg) in
complete or incomplete Freund´s adjuvant, at days 0, 14, 28. Two
weeks after the last immunization mice were sacrificed and spleens
and PECs were removed. Cells were dispersed manually and
centrifuged at 1,500 rpm for 5 min. Cells (1×106/well) were suspended
in complete culture medium and cultured for 72 h at 37°C and 5%
CO2 in 96-well plates with Fhmuc peptide (10 µg/ml), FhTE (50 µg/
ml), or medium alone. Secreted cytokine (IFNγ, IL-5) levels were
tested on culture supernatants by interleukin- specific sandwich ELISA
assays (BD Bioscience, NJ, USA).
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Cell analyses by flow cytometry
Splenocytes or PECs from infected and non-infected mice were
washed twice with PBS containing 2% FBS and 0.1% sodium azide.
Cells were then stained with different antibody mix to identify B and T
cells [anti-CD3 (17A2), -CD4 (RM4-5), -CD8α (53-6.7), -CD19 (eBio1
D3)]; NK cells [anti-NK1.1-PE (PK136), -CD69-FITC (H1.2F3) and -
CD49b-APC (DX5)]; regulatory T cells [CD4 (RM4-5), -CD25
(PC61.5), -FoxP3 (FJK-16s)]; dendritic cells and macrophages [anti-
CD11b (M1/70), -CD11c (N418), -CD40 (HM40-3), -MHC II
(m5/114.15.2), I-A/I-E (2G9), -F4/80 (BM8), -CD80 (16-10A1), -CD86
(GL1)]; or monocoytes and granulocytes [anti-CD11b (M1/70), -
Ly-6G (RB6-8C5), -Ly-6C (HK1.4), -Siglec-F (E50-2440)]. Cells were
then washed twice with PBS containing 5% FBS and 0.1% sodium
azide and fixed with 1% formaldehyde. Cell populations were analyzed
using a CyAn ADP Analyzer (Beckman Coulter). Antibodies were
obtained from eBioscience or from BD-Biosciences.
Dendritic cell maturation
Bone Marrow-derived Dendritic Cells (BMDCs) were generated
from bone marrow precursors from BALB/c or C57BL/6 mice. Briefly,
bone marrow precursor cells were harvested and plated at a density of
2-5×105 cells/ml in complete culture medium supplemented with GM-
CSF-containing supernatant. After 3 days of culture at 37°C, the
medium was replaced. Cells were recovered on day 8 and analyzed for
the expression of CD11c by flow cytometry. To induce DC-
maturation, BMDCs (2.5 × 105/well) were incubated at 37°C and 5%
CO2 in 96-well plates with FhTE, FhPox, FhB (75 µg/ml) or Fhmuc (10
µg/ml) or medium alone in the presence or absence of LPS
(Escherichia coli 0111:B4, 0.5-1 µg/ml), Zymosan-A (from S.
cerevisiae, 1 µg/ml) or poly:(IC) (50 µg/ml) overnight at 37°C. Cells
were then centrifuged at 1,500 rpm for 5 min at 4°C and supernatants
were then collected. Cytokine (IL-12/23p40, IL-10 and IL-6) levels
were tested on culture supernatants by interleukin specific sandwich
ELISA assays (BD Bioscience, NJ, USA). Results are expressed in
µg/ml.
To evaluate the capacity of BMDCs treated with Fhmuc and LPS to
stimulate F. hepatica specific T cells in vivo, loaded-BMDCs were
washed three times in culture medium, and then inoculated i.p. into
mice (1×106 cells/mouse). Ten days later, spleens and PECs were
removed and cultured in the presence of Fhmuc (10 µg/ml) or FhTE
(50 µg/ml) for 72 h at 37°C. IFNγ or IL-5 were detected on culture
supernatants by specific ELISAs.
Model of septic shock
Groups of four C57BL/6 mice were injected i.p. with Fhmuc (10 µg/
mouse) 2 h before i.p. injection with LPS (1 µg/mouse). Control mice
received PBS or Fhmuc in absence of LPS, or PBS plus LPS. Mice were
sacrificed 6 h later and bled. Serum concentrations of IFNγ and
IL-12/23p40 were measured by specific ELISAs.
Statistical Analysis
The Student t test was used for statistical comparisons; p values
<0.01 or <0.05 were considered to be statistically significant,
depending on the experiment.
Results
Glycans produced by F. hepatica modulate production of
IFNγ by splenocytes from infected animals
Helminths, and in particular F. hepatica, induce potent polarized
Th2/Treg immune responses, suppressing the production of Th1
cytokines [2-5]. Glycans are abundant on helminth surfaces as well as
in their excretory/secretory products [28] and can regulate or suppress
the host immune response to guarantee their survival [29]. In order to
evaluate whether F. hepatica glycans play a role in the modulation of
the host immune response at a systemic level, we evaluated the ability
of spleen cells from infected mice to produce IFNγ when re-stimulated
with a total parasite extract presenting intact (FhTE) or oxidized
(FhPox) glycans. To this end, we carried out a mild periodate
oxidation of glycol groups in carbohydrates to reactive aldehyde
groups, which are in turn reduced with sodium borohydride. Thus, the
structure of carbohydrates is lost, as well as the possible biological
activity that they can mediate. In agreement with previous results,
splenocytes from infected animals stimulated in vitro with F. hepatica
total extract (FhTE) produced only IL-5 (Figure 1A). In contrast, when
these cells were stimulated with oxidized FhTE (FhPox) they acquired
the capacity of producing IFNγ (Figure 1B), suggesting a role of
glycans in the inhibition of IFNγ by specific splenocytes. The control
FhB consisting in FhTE subjected to the whole treatment excepting for
the incubation with sodium periodate, induced the production of IL-5
in absence of IFNγ, as the FhTE, while the CPox, representing PBS
subjected to the entire treatment did not induce the production of
either IL-5 or IFNγ, as expected.
Infection with F. hepatica is associated to an increase of
dendritic cells, macrophages, eosinophils and regulatory T
cells in the peritoneal cavity
Considering that the periodate oxidation of glycans allowed the
production of IFNγ by specific-T cells in the spleens from infected
animals, we sought to characterize the lymphoid, as well as the
myeloid immune cells in these mice and determine whether F.
hepatica modulates the recruitment or activation of immune cells.
Thus, we carried out an extensive immunophenotyping of splenocytes
and cells from the peritoneum (PECs) from infected-mice by flow
cytometry. The percentage of CD11c+, CD11b+, CD11b+/F4/80+,
CD11b+/Ly6G+ Ly6C+, CD11b+/Ly6G- Ly6C+, CD11b+/SiglecF+,
CD19+ CD3-, CD3+ CD4+, CD3+ CD8+ or CD4+/CD25+ FoxP3+ cells
were determined in mice sacrificed after three weeks post-infection,
and compared to naïve animals.
Although the levels of T or B lymphocytes did not vary significantly,
except for CD3+ CD8+ T cells that were augmented in the peritoneum
and CD19+ B cells in the spleen, their activation status defined by the
expression of CD62L was considerably different (Figure 2).
Lymphocytes from the spleen of infected animals had lower levels of
CD62L expression than naive animals, while B or T cells from the
peritoneum up-regulated expression of CD62L, indicating that
lymphocytes in the spleen were activated following infection, while
naïve B and T cells were recruited at the peritoneum. Interestingly,
regulatory T cells (Tregs) defined as CD4+/CD25+FoxP3+ were
augmented in the spleen (Figure 2), which could be in agreement with
the inability of FhTE-stimulated splenocytes to produce IFNγ.
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Figure 1: Periodate-treatment of F. hepatica total lysate (FhPox)
enables the production of IFNγ by splenocytes from infected
animals. A) Splenocytes from infected or naïve animals were
stimulated in vitro with total lysate FhTE (75 µg/ml) for 72 h at
37°C. IFNγ and IL-5 were detected in culture supernatants by
specific ELISA. B) Splenocytes from infected animals were
stimulated in vitro with total lysate FhTE (75 g/ml), periodate
oxidized-lysate (FhPox, 75 g/ml) and incubated for 72 h at 37°C.
IFNΓγ and IL-5 were detected in culture supernatants by specific
ELISA. Controls consisted in the FhTE lysate incubated only with
borhydrure (FhB), or PBS subjected to the complete periodate
treatment (CPox). Results are expressed as mean value of triplicates
(± SD, indicated by error bars), and are representative of three
different experiments. Asterisks represent differences statistically
significant (*p <0.01).
Regarding the phenotyping of myeloid cells, the percentage of
CD11chigh (CD11chi) cells was decreased in the spleens of infected
animals (Figure 2A), while they were augmented in the peritoneal
cavity (Figure 2B), suggesting that DCs are recruited to the
peritoneum. On the other hand, the percentage of CD11b+/F4/80+
cells was increased in the peritoneal cavity, indicating a recruitment of
macrophages to the peritoneum (Figure 2B). Furthermore, CD11b+/
Siglec F+ cells were augmented both in the spleen and in the peritoneal
cavity of infected mice, which would account for the production of
IL-5 on stimulated splenocytes. No significant changes were observed
in the percentage of CD11b+/Ly6G+ Ly6C+, CD11b+/Ly6G- Ly6C+
cells (Figure 2).
F. hepatica induces a semi-mature phenotype of DCs during
infection
Previous in vitro reports have shown that parasite products from F.
hepatica suppress maturation and function of bone marrow DCs
(BMDCs) [9-10]. Thus, we investigated in vivo the maturation status
of DCs from infected animals. After three weeks of infection, infected
BALB/c mice presented CD11chi cells in the peritoneum that were
characterized by an up-regulation of CD80 and CD86 expression, and
a down-regulation of MHC class II expression, as compared to naïve
mice (Figure 3A). MHC class II was also decreased on CD11chi cells in
the spleen, while the other co-stimulatory markers were unchanged
(Figure 3B). CD11chi cells from C57BL/6 mice behaved essentially in a
similar way except for the fact that CD11chi cells from spleens of
infected animals showed similar levels of MHCII expression than
naïve mice, while they down-regulated CD40 expression (Figure 3C-
D). These results suggest that DCs adopt a semi-mature phenotype
during infection with F. hepatica, characterized by a reduced
expression of MHC class II on their surface.
Figure 2: Immunophenotyping of cells from the spleen or
peritoneum from F. hepatica- infected or naïve mice. BALB/c mice
were challenged with 5 metacercariae and after three weeks from
infection, splenocytes (A) and PECs (B) were removed, incubated
with specific antibodies, and analyzed by flow cytometry. Fifty
thousand events were collected and gated on FSC vs SSC dot plot.
For the identification of granulocytes or macrophages, cells were
first gated on CD11b+ dots; and for Tregs, cells were first gated on
CD4+, and then double positive dots for CD25 and Foxp3 were
gated. Results are expressed as mean value of triplicates (± SD,
indicated by error bars), each value meaning a single mouse and are
representative of two different experiments. Asterisks represent
differences statistically significant (*p<0.01, **p<0.05).
F. hepatica glycans modulate DC-maturation
In agreement with previous evidences indicating that parasite
products from F. hepatica can partially inhibit TLR-induced
maturation [8-10], BMDCs co-incubated with a parasite total extract
(FhTE) and with zymosan (ligand for TLR2), poly:(IC) (TLR3 agonist)
or LPS (TLR4 ligand), produced lower levels of IL-12/23p40 than the
cell stimulated with the TLR ligand alone (Figure 4A). Next, we
investigated whether carbohydrate structures produced by F. hepatica
were involved in the modulation of DCs. When BMDCs were co-
incubated with FhTE, IL-6 and IL12/23p40 LPS-induced production
by DCs was significantly decreased, while the production of IL-10 was
incremented (Figure 4B). On the other hand, when BMDCs were
cultured in presence of LPS and periodate-treated parasite total lysate
(FhPox) the levels of the pro-inflammatory cytokines IL-12/23p40,
IL-6 or IL-10 were equivalent to those obtained with LPS alone,
partially abolishing the inhibition of the LPS-induced DC maturation
by F. hepatica (Figure 4B). As expected, the control FhB/LPS behaved
essentially in the same way as FhTE/LPS, while the CPox/LPS induced
the same levels of cytokine production than the LPS condition.
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Figure 3: Dendritic cells from infected animals present a semi-
mature phenotype. BALB/c (A-B) or C57BL/6 (C-D) mice were
challenged with 5 or 10 metacercariae, respectively, and after three
weeks from infection, splenocytes and PECs were removed, and
incubated with anti-mouse CD40-FITC, CD80-PeCy5, CD86-APC
and MHC-II-PE for 30 min at 4°C. Cells were analyzed by flow
cytometry. Fifty thousand events were collected and gated on FSC
vs. SSC dot plot, and then gated on CD11c+ dot plot. Results are
expressed as mean value of quintuplicates (± SEM, indicated by
error bars), each value meaning a single mouse and are
representative of two different experiments. Asterisks represent
differences statistically significant (*p<0.01).
A mucin-like peptide from F. hepatica synergizes with LPS to
induce DC-maturation and triggers a F. hepatica-specific
Th1-like immune response
Mucin-like molecules expressed by parasites participate in
attachment and invasion of host cells among other processes, by
providing proteases resistance or avoiding immune recognition
[20,29]. During a characterization of the transcriptome of F. hepatica
newly excysted juveniles (NEJ) a cDNA clone coding for a mucin-like
protein has been identified [27]. The predicted protein, characterized
by repeated Ser and Thr residues predicted to be O-glycosylated, is the
most frequent in the juvenile ESTs and was found that it is
predominantly expressed by qRT-PCR in the invasive stage [27]. In an
attempt to evaluate whether this mucin-like peptide could mount an
immune response directed to F. hepatica, we immunized mice with a
synthetic 66-mer non-glycosylated peptide (referred here as Fhmuc)
carrying a partial sequence of the identified mucin. A non-glycosylated
Fhmuc peptide was used in order to avoid possible
immunosuppressive effects by parasite glycans. To this end, cells from
the spleen or the peritoneal cavity of mice immunized i.p. with the
Fhmuc peptide were stimulated in vitro with Fhmuc or with parasite
derived-molecules (FhTE). PECs mainly reacted to the stimulation
both with Fhmuc or parasite products by producing high levels of
IFNγ, in absence of IL-5, while spleen cells did not produce significant
levels of either IFNγ or IL-5 upon antigen stimulation (Figure 5A).
These data indicate that Fhmuc induces a Th1-like response able to
recognize F. hepatica antigens.
Figure 4: Periodate-treatment of F. hepatica total lysate restores the
IL-6 and IL-12/23p40 cytokine levels produced by DCs
simultaneously treated with FhTE and LPS. A) BMDCs were
incubated with FhTE in presence of LPS (1 g/ml), Zymosan (1
g/ml) or poly: (IC) (50 µg/ml) overnight at 37°C. Then IL-12/23p40
levels were detected on culture supernatants. B) BMDCs were
incubated with total lysate FhTE (75 g/ml), periodate oxidized-
lysate (FhPox, 75 g/ml) in absence or presence of LPS and
incubated overnight at 37°C. Then IL-12/23p40 levels were detected
on culture supernanatants Controls consisted in FhTE lysate
incubated only with borhydrure (FhB), or PBS subjected to the
complete periodate treatment (CPox). ND stands for “not done”.
Results are expressed as mean value of triplicates (± SD, indicated
by error bars), and are representative of three different
experiments. Asterisks represent differences statistically significant
(*p<0.01, **p<0.05).
Next, we investigated possible pro-inflammatory properties of
Fhmuc. Due to the fact that previous data have shown that F. hepatica
suppresses a protective Th1 response against Bordetella pertussis [30]
we sought to study whether Fhmuc could also modify the levels of pro-
inflammatory cytokines induced by LPS in a model of septic shock.
Thus, we injected Fhmuc i.p. followed by LPS, and 6 h later, we
evaluated the levels of IL-12/23p40 and IFNγ in serum. Control
animals were injected with PBS followed by LPS administration. As
seen in Figure 5B, sera from animals stimulated with Fhmuc and LPS,
presented significant higher levels of IL-12/23p40 and IFNΓγ, as
compared as to animals inoculated with LPS alone.
Considering the capacity of Fhmuc to synergize with LPS in the
production of the pro-inflmmatory cytokines IL-12/23p40 and IFNΓγ,
we then evaluated whether Fhmuc could enhance the maturation of
DCs induced by LPS. BMDCs incubated with Fhmuc followed by LPS
produced higher levels of IL-12/23p40 or IL-6 than BMDCs stimulated
only with LPS. These treated BMDCs, when injected i.p. induced an
immune response that recognized parasite products, as detected by the
production of IFNγ by splenocytes stimulated with Fhmuc or FhTE
(Figure 5C). Overall, these data indicate that Fhmuc synergizes with
LPS in inducing DC maturation, and that BMDCs loaded with Fhmuc
can induce immune responses specific to F. hepatica, characterized by
high production of IFNΓγ.
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Figure 5: The mucin-like peptide Fhmuc induces specific immune
response characterized by a strong production of IFNγ. A) C57BL/6
mice were immunized i.p. with Fhmuc (10 g) or PBS (control
group) at days 0, 14, 28. At day 42, spleens and PECs were removed
and cultured with Fhmuc peptide (10 µg/ml) or FhTE (20 µg/ml).
Secreted cytokines (IFNγ, IL-5) were tested on culture supernatants
by interleukin-specific sandwich ELISA assays. B) Mice were
inoculated i.p. Fhmuc (10 µg/ml) and 2 h later LPS (1 µg/ml) was
administrated. IL12/23p40 and IFNγ levels were tested in sera after
6 h of LPS administration. C) BMDCs were incubated with Fhmuc
(10 µg/ml) and 2 h later LPS was added and cells were incubated
overnight at 37°C. Then IL-12/23p40, IL-6 and IL-10 levels were
detected on culture supernatants. D) BMDCs treated with Fhmuc
and LPS overnight at 37°C were washed and inoculated i.p. at 1×106
cells/mouse. Ten days later, spleens and PECs were removed and
cultured in the presence of Fhmuc (10 µg/ml) or FhTE (50 µg/ml).
IFNγ or IL-5 was detected on culture supernatants by specific
ELISA. Results are expressed as mean value of triplicates (± SD,
indicated by error bars) and are representative of two different
experiments. Asterisks represent differences statistically significant
(*p<0.01, **p<0.05).
Discussion
In this work we show that F. hepatica is able to modulate the
immune response of its host at different levels. First, we confirm that
macrophages and eosinophils are recruited to the periotoneal cavity as
previously described by Walsh and collaborators [2]. Additionally, we
show that Tregs are augmented in the spleen of infected animals.
Moreover, we show that there is an increase of DCs in the peritoneum
characterized by a semi-mature phenotype associated to an important
decrease of MHC class II expression and an up-regulation of the co-
stimulatory molecules CD80 and CD86. The expression of MHC class
II-peptide complexes on the surface of DCs is essential for their ability
to activate CD4+ T cells efficiently. Apparently, DCs from F. hepatica-
infected animals would present a reduced capacity of antigen
presentation to prime specific CD4+ T cells, as suggested by the low
levels of MHC class II expression on DCs. It has been previously
shown that ubiquitination of MHCII-peptide complexes regulates
their surface expression, retention and degradation in DCs [31-33],
and that certain pathogens, such as Salmonella typhimurium, induce
polyubiquitination of HLA-DR, resulting in a reduced surface
expression of all MHC class II isotypes [34]. On the other hand, there
are evidences reporting that Mycobacterium tuberculosis diminishes
MHC-II synthesis by macrophages [35] in a process dependent on
TLR2 ligation [36], limiting antigen presentation. It would be
interesting to evaluate whether any of these molecular mechanisms
underlie the reduced expression of MHC class II on the surface of DCs
from F. hepatica-infected animals.
We also provide evidence indicating that glycan structures from F.
hepatica are responsible, at least in part, for inhibiting LPS-induced
DC maturation and production of IFNγ by splenocytes from infected
animals. Clearly, these results indicate that the development of a
vaccine involving oxidized parasite glycoconjugates, or even DCs
loaded with those molecules, would constitute a useful strategy for the
design of vaccines against fasciolosis. Parasite glycans, and in
particular from helminths, mediate diverse functions that might
involve infectivity and pathogenesis, or immune evasion mechanisms.
For instance, Schistosoma mansoni, through a glycosylated RNAse
that is recognized by the mannose receptor on DCs, impairs protein
synthesis of IL-12 by degrading both ribosomal and messenger RNA,
leading to a Th2-polorized T-cell response [37]. On the other hand,
glycans from the nematode Brugia malayi were reported to participate
in the induction of the specific Th2 immune response, since sodium
periodate-treated soluble extracts from these parasite induced lower
levels of IL-4 by specific lymph node cells [38]. Also, the glycans of the
whipworm Trichuris suis mediate the suppression of TNFα
production by DCs stimulated with LPS [39]. Helminth glycans are
recognized by C-type lectins on DCs, which might in turn suppress
TLR signaling [40]. Indeed T. suis glycans interact with the mannose
receptor, DC-SIGN and MGL, which recognized mannose residues or
terminal GalNAc, respectively [39].
Regarding F. hepatica glycans, their role in alternative activation of
macrophages has been reported by treating glycans with periodate [13]
or by inhibiting macrophage binding using antibodies specific for C-
type lectin receptors [22], although no evidence is available about their
function on DC maturation. Here, we show that glycans from F.
hepatica are involved in the modulation of LPS-induced maturation of
DCs and that their oxidation restores the capacity of LPS-treated DCs
to secrete high levels of the pro-inflammatory cytokines IL-6 and IL-12
and low levels of the anti-inflammatory cytokine IL-10. We are
currently working on the identification of these glycans and the C-type
lectin receptors on DCs that participate in their recognition.
On the other hand, we show that a mucin-like peptide from F.
hepatica (Fhmuc) is able to synergize with LPS in inducing DC-
maturation, and that it induces a T cell response specific for F.
hepatica, both alone or in combination with DCs. The fact that this
peptide was identified to be highly expressed in the NEJ infective stage
of the parasite, suggests that it could be a good vaccine candidate, since
a vaccine targeting the NEJ, able to suppress or eliminate invasion of
the liver parenchyma, would minimize liver pathology and reduce
production loses in livestock.
Up to date, vaccination assays with either purified native or
recombinant proteins from F. hepatica, have been carried out mostly
using proteases, hemoglobin, glutathione S-transferase or fatty acid
binding proteins as immunogens [41]. These studies provided a
diverse range of protection (30-80%), in ruminants. Interestingly, the
protection level was augmented when used a combination of two
different cathepsins (CL1 and CL2), comparing to the use of the
proteases alone (60% versus 34% of protection) [42]. Thus, the use of
one of these already evaluated immunogens together with a pro-
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inflammatory antigen highly expressed in the infective stage of the
parasite, such as Fhmuc, might constitute an attractive alternative to
augment the level of protection. At the moment, we are evaluating the
capacity of Fhmuc-loaded DC to induce specific cellular immunity
against F. hepatica and its potential of protecting from liver damage.
In conclusion, this paper highlights the importance of glycans in
driving Th2-like immune responses by F. hepatica and in modulating
TLR-induced maturation of DCs. Furthermore, we present a mucin-
like peptide from F. hepatica, that induces specific immune responses
and that is able to synergize with LPS in inducing pro-inflammatory
cytokines by matured DCs. These data might contribute to the
understanding of the mechanisms that F. hepatica uses to modulate
the host immune response, and to the design of vaccines against
fasciolosis. We are currently evaluating the protective potential against
fasciolosis in mice vaccinated with Fhmuc-DC.
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